Mallory E. Bowers

Mallory E. Bowers

Auto-generated profile, based on publicly available information

Mallory E. Bowers

James J. Peters Veterans Affairs Medical Center

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 August 2015 in Neuropsychopharmacology
Verified
Journal Article
Closed access
MBMallory E Bowers
Mallory E Bowers
RYRachel Yehuda
Rachel Yehuda


1 December 2012 in Physiology & Behavior
Verified
Journal Article
Closed access
MBMallory E. Bowers
Mallory E. Bowers
DCDennis C. Choi
Dennis C. Choi
KRKerry J. Ressler
Kerry J. Ressler

19 June 2013 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
AJAaron M. Jasnow
Aaron M. Jasnow
DEDavid E. Ehrlich
David E. Ehrlich
DCDennis C. Choi
Dennis C. Choi
JDJoanna Dabrowska
Joanna Dabrowska
MBMallory E. Bowers
Mallory E. Bowers
KRKerry J. Ressler
Kerry J. Ressler
Research has identified distinct neuronal circuits within the basolateral amygdala (BLA) that differentially mediate fear expression versus inhibition; however, molecular markers of these populations remain unknown. Here we examine whether optogenetic activation of a cellular subpopulation, which may correlate with the physiologically identified extinction neurons in the BLA, would differentially support fear conditioning versus fear inhibition/extinction. We first molecularly characterized Thy1-channelrhodopsin-2 (Thy1-ChR2-EYFP)-expressing neurons as a subpopulation of glutamatergic pyramidal neurons within the BLA. Optogenetic stimulation of these neurons inhibited a subpopulation of medial central amygdala neurons and shunted excitation from the lateral amygdala. Brief activation of these neurons during fear training disrupted later fear memory in male mice. Optogenetic activation during unreinforced stimulus exposure enhanced extinction retention, but had no effect on fear expression, locomotion, or open-field behavior. Together, these data suggest that the Thy1-expressing subpopulation of BLA pyramidal neurons provide an important molecular and pharmacological target for inhibiting fear and enhancing extinction and for furthering our understanding of the molecular mechanisms of fear processing.

16 March 2015 in Learning & Memory
Verified
Journal Article
Open access
PDF file
MBMallory E. Bowers
Mallory E. Bowers
BXBing Xia
Bing Xia
SCSamantha Carreiro
Samantha Carreiro
KRKerry J. Ressler
Kerry J. Ressler
Evidence indicates that broad, nonspecific histone deacetylase (HDAC) inhibition enhances learning and memory, however, the contribution of the various HDACs to specific forms of learning is incompletely understood. Here, we show that the Class I HDAC inhibitor, RGFP963, enhances consolidation of cued fear extinction. However, RGFP966, a strong inhibitor of HDAC3, does not significantly enhance consolidation of cued fear extinction. These data extend previous evidence that demonstrate the Class I HDACs play a role in the consolidation of long-term memory, suggesting that HDAC1 and/or HDAC2, but less likely HDAC3, may function as negative regulators of extinction retention. The development of specific HDAC inhibitors, such as RGFP963, will further illuminate the role of specific HDACs in various types of learning and memory. Moreover, HDAC inhibitors that enhance cued fear extinction may show translational promise for the treatment of fear-related disorders, including post-traumatic stress disorder (PTSD).

1 September 2014 in Neuropsychopharmacology
Verified
Journal Article
Open access
PDF file
MBMallory E Bowers
Mallory E Bowers
KRKerry J Ressler
Kerry J Ressler
Post-traumatic stress disorder (PTSD) is thought to develop, in part, from improper inhibition of fear. Accordingly, one of the most effective treatment strategies for PTSD is exposure-based psychotherapy. Ideally, neuroscience would inform adjunct therapies that target the neurotransmitter systems involved in extinction processes. Separate studies have implicated the cholecystokinin (CCK) and endocannabinoid systems in fear; however, there is a high degree of anatomical colocalization between the cannabinoid 1 receptor (Cnr1) and CCK in the basolateral amygdala (BLA), a brain region critical for emotion regulation. Although most research has focused on GABA and GABAergic plasticity as the mechanism by which Cnr1 mediates fear inhibition, we hypothesize that a functional interaction between Cnr1 and CCKB receptor (CCKBR) is critical for fear extinction processes. In this study, systemic pharmacological manipulation of the cannabinoid system modulated cued fear expression in C57BL/6J mice after consolidation of auditory fear conditioning. Knockout of the CCKBR, however, had no effect on fear- or anxiety-like behaviors. Nonetheless, administration of a Cnr1 antagonist increased freezing behavior during a cued fear expression test in wild-type subjects, but had no effect on freezing behavior in CCKBR knockout littermates. In addition, we found that Cnr1-positive fibers form perisomatic clusters around CCKBR-positive cell bodies in the BLA. These CCKBR-positive cells comprise a molecularly heterogenous population of excitatory and inhibitory neurons. These findings provide novel evidence that Cnr1 contributes to cued fear expression via an interaction with the CCK system. Dysfunctional Cnr1–CCKBR interactions might contribute to the etiology of, or result from, fear-related psychiatric disease.